12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Eisai, Yiaco Medical Co. sales and marketing update

Eisai partnered with Yiaco to immediately launch cancer drug Halaven eribulin in Kuwait, where it was approved last October....

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >